Filter
564
Filtered Results: 564
Text search:
pharmacovigilance
Featured
Recommendations
64
New Publications
164
Language
Document type
No document type
268
Guidelines
116
Studies & Reports
80
Strategic & Response Plan
30
Manuals
28
Fact sheets
16
Resource Platforms
8
Training Material
7
Situation Updates
4
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Congo, Democratic Republic of
17
South Africa
17
India
17
Ghana
16
Global
16
Nigeria
15
Western and Central Europe
14
Uganda
14
Senegal
12
Eastern Europe
12
Rwanda
11
Ethiopia
11
Nepal
10
Latin America and the Carribbean
10
Namibia
10
West and Central Africa
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Zambia
8
Madagascar
8
Africa
7
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Cameroon
2
Syria
2
Morocco
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Laos
1
Afghanistan
1
Burundi
1
Guinea
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
281
Clinical Guidelines
59
Public Health
16
Pharmacy & Technologies
10
Capacity Building
8
Women & Child Health
8
Key Resources
7
Toolboxes
Pharmacy
73
COVID-19
62
TB
55
AMR
46
NTDs
27
HIV
23
Malaria
12
Rapid Response
6
Ebola & Marburg
6
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
NEMLIST | Sixth Edition | February 2016
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
Par ses propriétés thérapeutiques, le médicament permet aux professionnels de santé
ainsi quaux pouvoirs publics dassurer la santé des populations. De ce fait, sa disponibilité et
son efficacité sont essentielles et sont le résultat dun circuit complexe (de sa fabrication...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen...
Towards universal access
Accessed November 2017
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
14–22 April 2015
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Le profil pharmaceutique du pays présente des données sur les conditions socioéconomiques existantes et celles de la santé, les ressources, les structures règlementaires, les processus et les résultats relatifs au secteur pharmaceutique au Burkina-Faso. Ce document a pour but de compiler toute...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
